Conduit Pharmaceuticals
CDT • NASDAQ • Stock Fundamentals
Conduit Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Andrew Regan, with a market cap of $4.3M.
Market Cap$4.3M
Employees7.0
CEOAndrew Regan
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 28, 2026 · todayQ1 2026
View reportFinancials
Based on Q1 2026 filing
CDT
Conduit Pharmaceuticals FAQ
Common questions about Conduit Pharmaceuticals
Conduit Pharmaceuticals (CDT) has a market capitalization of $4.3M and trades on NASDAQ.
Conduit Pharmaceuticals has approximately 7 employees.